Intervention Summary
Drugs: True Stories
         Drugs: True Stories is a multimedia intervention designed to prevent drug use among young people in grades 5-12 by positively changing the attitudes of youth and their parents and other caregivers in regard to the use of drugs. The intervention features a 30-minute video, which includes two vignettes of teenagers telling their personal stories to illustrate the harms associated with drug use, how teenagers and their families can work together to help teenagers abstain from drug use, possibilities for teenagers to recover from drug dependence, and how making smart choices can save lives. Program content includes the following topics: risks of drug experimentation, denial by the user and family members, addiction, recovery, and the benefits of avoiding drug use. The video is accompanied by a discussion guide, which is designed to provoke candid conversation regarding drug use and offers questions for youth, parents, and caregivers who are participating in the program. The intervention can be delivered in its entirety or in segments (e.g., three 50-minute sessions). A 1-day training on program implementation is available. The study reviewed for this summary assessed only the video, without the discussion guide. In addition, the study reported results for youth only. 
                            The documents below were reviewed for Quality of Research. The research point of
                            contact can provide information regarding the studies reviewed and the availability
                            of additional materials, including those from more recent studies that may have been conducted. Division on Addictions. Evaluating the promise of a drug education video. Summary report: Drugs: True Stories. Medford, MA: Author. 
                            The following populations were identified in the studies reviewed for Quality of
                            Research. 
                            External reviewers independently evaluate the Quality of Research for an intervention's
                            reported results using six criteria: 
                            For more information about these criteria and the meaning of the ratings, see Quality of Research.
                         The survey has face and predictive validity and appears to be culturally appropriate for a wide range of students. The survey was constructed so that it was not possible for participants to determine the video that was under evaluation. Data were analyzed to assess baseline similarities between participants who were eliminated from the study because of data inconsistencies and participants who were included; no baseline differences were found between these two groups. Attrition was low, and there was a minimal amount of missing data. Participants were randomly assigned to either the intervention group or the active-intervention comparison group. Confounding variables were appropriately controlled (e.g., responses were anonymous and confidential; pre- and posttests were linked through identification numbers). Analyses are well delineated for the study design. There is inadequate documentation of reliability and construct validity, and the survey has not been pilot tested for use with the groups targeted for this study. No outside assessment was conducted to confirm that both treatment and comparison interventions were delivered with fidelity. It was not determined whether there were differences between students who consented to participate in the study and those who did not. No follow-up analyses were conducted to determine whether the intervention had lasting effects beyond the immediate impact after delivery of the intervention. It was noted that because multiple sites were used to obtain a sufficient sample, there were not enough cases per site to confidently examine differences among sites. 
                                The materials below were reviewed for Readiness for Dissemination. The implementation
                                point of contact can provide information regarding implementation of the intervention
                                and the availability of additional, updated, or new materials. Blake Works, Inc. Drugs: True Stories [DVD]. Gloucester, MA: Author. Blake Works, Inc. Drugs: True Stories discussion guide. Gloucester, MA: Author.  Blake Works, Inc. Drugs: True Stories facilitator's PowerPoint [DVD]. Gloucester, MA: Author. Blake Works, Inc. Drugs: True Stories train the trainer facilitator workbook. Gloucester, MA: Author. Blake Works, Inc. Drugs: True Stories train the trainer participant workbook. Gloucester, MA: Author. 
                                    External reviewers independently evaluate the intervention's Readiness for Dissemination
                                    using three criteria: For more information about these criteria and the meaning of the ratings, see Readiness for Dissemination.
                                 This program is an easily implemented intervention that can be delivered in a variety of settings and in a flexible number of sessions, depending on the needs of implementers. The program's video features a question-and-answer segment with two addiction experts that can be used in various combinations over multiple sessions, and the accompanying discussion guide includes icons that indicate whether questions are for children or parents. The developer provides training on the content of the program, which includes role-playing to facilitate skill building among implementers. The developer also provides implementers with additional tips for leading an effective discussion while incorporating the key lessons from the program. The developer provides a quiz to test what implementers have learned. Well-scripted program materials and comprehensive guidance concerning group facilitation heighten the program's quality assurance. No written guidance is given for adapting the intervention for use in community workshops or homes. There is no information on how parents, whether as in-home implementers or as a support mechanism for their children, should discuss the program content with their children. There are no specific instructions on how parents access training in order to implement the program at home with their children. It is unclear if, or how, the classroom activities in the Train the Trainer Participant Workbook should be used during implementation. No fidelity monitoring or outcome measures are available. The sole quality assurance tool (a quiz for implementers in the training materials) lacks guidance on administration. 
                The cost information below was provided by the developer. Although this cost information
                may have been updated by the developer since the time of review, it may not reflect
                the current costs or availability of items (including newly developed or discontinued
                items). The implementation point of contact can provide current information and
                discuss implementation requirements. Discounts are available for bulk orders, and price quotes are available upon request. Descriptive Information
        
    
             
        
                Areas of Interest
             
            
                Substance use disorder prevention
             
        
             
        
                Outcomes
             
            
                  
        
1: Behavioral intentions regarding illicit drug use
            
             
        
                Outcome Categories
             
            
                Drugs
             
        
             
        
                Ages
             
            
                13-17 (Adolescent) 
        
18-25 (Young adult)
            
             
        
                Genders
             
            
                Male 
        
Female
            
             
        
                Races/Ethnicities
             
            
                Data were not reported/available.
             
        
             
        
                Settings
             
            
                School
             
        
             
        
                Geographic Locations
             
            
                Suburban
             
        
             
        
                Implementation History
             
            
                Drugs: True Stories has been implemented by more than 5,000 middle and high schools and youth, parenting, and substance abuse organizations in all 50 States and in Australia, Canada, and Germany.
             
        
             
        
                NIH Funding/CER Studies
             
            
                Partially/fully funded by National Institutes of Health: No 
        
Evaluated in comparative effectiveness research studies: Yes
            
             
        
                Adaptations
             
            
                No population- or culture-specific adaptations of the intervention were identified by the developer.
             
        
             
        
                Adverse Effects
             
            
                No adverse effects, concerns, or unintended consequences were identified by the developer.
             
        
             
    
                IOM Prevention Categories
             
            
                Universal
             
        
    
    
     
    
     
    
              
        
                 
              
                  
                   
                      Documents Reviewed
                        Study 1
Outcomes
                       
                                    
                        
                                         
                                    Outcome 1: Behavioral intentions regarding illicit drug use 
                                    
                                         
                                    
                                            Description of Measures
                                         
                                        
                                            Behavioral intentions regarding illicit drug use were assessed using 3 items from the Helping Youth Make Smart Choices Survey, which was developed for the study. Using the self-report survey, participants indicated the likelihood that they "will use illicit drugs this weekend," "have a family discussion about teenage illicit drug use this coming week," and "have a discussion with friends about teenage illicit drug use this coming week." Response options included "not at all likely," "somewhat likely," and "extremely likely." Assessments occurred immediately before (pretest) and after (posttest) the intervention.
                                         
                                    
                                         
                                    
                                            Key Findings
                                         
                                        
                                            Students attending schools in Minnesota or Massachusetts were randomly assigned to view one of two 30-minute videos, either Drugs: True Stories or Boys on Bullying. From pre- to posttest, the percentage of students who reported that they were somewhat or extremely likely to have a family discussion about teenage illicit drug use in the coming week increased for those who viewed Drugs: True Stories (p < .05) and decreased for those who viewed Boys on Bullying (p < .05). The difference between conditions was significant (p < .05).
                                         
                                    
                                         
                                    
                                            Studies Measuring Outcome
                                         
                                        
                                            Study 1
                                         
                                    
                                         
                                    
                                            Study Designs
                                         
                                        
                                            Experimental
                                         
                                    
                                         
                                
                                            Quality of Research Rating
                                         
                                        
                                            2.3
                                            (0.0-4.0 scale)
                                         
                                    Study Populations
                        
                                
                        
                                     
                                        
                                        Study
                                     
                                    
                                        Age
                                     
                                    
                                        Gender
                                     
                                    
                                        Race/Ethnicity
                                     
                                
                                             
                            
                                                
                                                    Study 1
                                                
                                             
                                            
                                                13-17 (Adolescent) 
                                            
18-25 (Young adult)
                                            
                                                59.7% Female 
                                            
40.3% Male
                                            
                                                Data not reported/available
                                             
                                        
                            Quality of Research Ratings by Criteria (0.0-4.0 scale)
                        
                                    
                            
                            
                        
                                 
                                    
                                    Outcome
                                 
                                
                                    Reliability 
                                
                                    of Measures
                                
                                    Validity 
                                
                                    of Measures
                                
                                    Fidelity
                                 
                                
                                    Missing 
                                
                                    Data/Attrition
                                
                                    Confounding 
                                
                                    Variables
                                
                                    Data 
                                
                                    Analysis
                                
                                    Overall 
                            
                                    Rating
                                
                                         
                        
                                            1: Behavioral intentions regarding illicit drug use
                                         
                                        
                                            1.8
                                         
                                        
                                            2.8
                                         
                                        
                                            1.5
                                         
                                        
                                            2.5
                                         
                                        
                                            2.5
                                         
                                        
                                            2.5
                                         
                                        
                                            
                                                2.3
                                         
                                    Study Strengths 
Study Weaknesses 
     
                     
        
                 
            
                    
                                Materials Reviewed
                            
                                    Readiness for Dissemination Ratings by Criteria (0.0-4.0 scale)
                                
                                    
                                    
                                    
                            
                                         
                                            
                                            Implementation
                                             
                                        
                                            Materials
                                        
                                            Training and Support
                                             
                                        
                                            Resources
                                        
                                            Quality Assurance
                                             
                                        
                                            Procedures
                                        
                                            Overall
                                             
                                    
                                            Rating
                                        
                                                 
                                
                                                    3.3
                                                 
                                                
                                                    3.8
                                                 
                                                
                                                    1.5
                                                 
                                                
                                                
                                                    2.8
                                                 
                                            Dissemination Strengths 
 Dissemination Weaknesses 
 
     
                
            
                     
                        
                        Item Description
                     
                    
                        Cost
                     
                    
                        Required by Developer
                     
                
                             
                        
                                Drugs: True Stories (DVD) (includes the discussion guide)
                             
                            
                                $99.99 each
                             
                            
                                Yes
                             
                        
                             
            
                                1-day training
                             
                            
                                Varies depending on training location and number of participants
                             
                            
                                No
                             
                        Additional Information